Cleaning Validation Limits: Calculating MACO, PDE, and Swab Recovery Studies
Multi-product manufacturing lines must prove zero toxicological carryover between product shifts. The regulatory expectation for cleaning validation is to prevent cross-contamination that could affect patient safety. This guide reviews the toxicological limits used to determine cleaning validations, detailing Permitted Daily Exposure (PDE) and Maximum Allowable Carryover (MACO) calculations.
Toxicological vs. Visual Limits
In the past, the industry relied on simple rules of thumb, such as \"10 ppm of active ingredient in the next product\" or \"visually clean.\" Modern guidelines (EMA and FDA) require scientific calculations based on toxicological data. Visual inspection remains a critical first line of check, but it must be backed by swab and rinse sample assays.
Calculating Permitted Daily Exposure (PDE)
The Permitted Daily Exposure (PDE) represents the dose of active substance that is unlikely to cause adverse health effects if consumed daily. The formula is:
PDE = (NOAEL × Weight Adjustment) / (F1 × F2 × F3 × F4 × F5)
Where **NOAEL** is the No Observed Adverse Effect Level, and F1 through F5 represent uncertainty factors that account for inter-species variation, human variability, study duration, toxicological severity, and database completeness. If NOAEL is unavailable, the Lowest Observed Adverse Effect Level (LOAEL) is used with an additional correction factor.
Determining Maximum Allowable Carryover (MACO)
Once the PDE of Product A is established, we calculate the Maximum Allowable Carryover (MACO) of Product A into Product B. The calculation depends on the minimum daily dose of Product B and its batch size:
MACO = (PDE_A × Batch Size_B) / Max Daily Dose_B
Designing Swab Recovery Studies
To verify that our sampling method can detect residues, we must perform swab recovery studies. Quality teams spike representative equipment surfaces (such as stainless steel, glass, or Teflon) with known trace amounts of Product A. The surface is then swabbed and assayed using validated analytical methods (typically HPLC or TOC). The recovery factor must be determined (typically >70%) to correct the final analysis results of cleaning checks. Regular validation protocols ensure cleaning processes remain robust and safe.
Subscribe to our monthly GMP newsletter
Receive Hyderabad pharmaceutical regulatory updates directly to your inbox.
Join Newsletter List